BACKGROUND: Next generation sequencing has yielded an unparalleled means of quickly determining the molecular make-up of patient tumors. In conjunction with emerging, effective immunotherapeutics for a number of cancers, this rapid data generation necessitates a paired high-throughput means of predicting and assessing neoantigens from tumor variants that may stimulate immune response. RESULTS: Here we offer NeoPredPipe (Neoantigen Prediction Pipeline) as a contiguous means of predicting putative neoantigens and their corresponding recognition potentials for both single and multi-region tumor samples. NeoPredPipe is able to quickly provide summary information for researchers, and clinicians alike, on predicted neoantigen burdens while provid...
Tumor-specific peptide epitopes that are generated from mutated genes and presented on cell surface ...
Abstract Background Tumor neoantigens are drivers of cancer immunotherapy response; however, current...
The remarkable clinical efficacy of the immune checkpoint blockade therapies has motivated researche...
Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tu...
Background: Tumor-specific mutations form novel immunogenic peptides called neoantigens. Neoantigens...
BACKGROUND The use of next-generation sequencing technologies has enabled the rapid identificatio...
Neoantigens are newly formed peptides formed by somatic mutations that are capable of inducing tumor...
Neoantigens are novel peptide sequences resulting from sources such as somatic mutations in tumors. ...
abstract: Cells become cancerous due to changes in their genetic makeup. In cancers, an altered amin...
The field of cancer neoantigen investigation has developed swiftly in the past decade. Predicting no...
Lack of a dedicated integrated pipeline for neoantigen discovery in mice hinders cancer immunotherap...
The field of cancer neoantigen investigation has developed swiftly in the past decade. Predicting no...
Cancer immunotherapy has become a new pillar of cancer treatment. However, durable clinical benefits...
The human adaptive immune system is programmed to distinguish between self and non-self proteins and...
BACKGROUND: Immune escape is one of the hallmarks of cancer and several new treatment approaches att...
Tumor-specific peptide epitopes that are generated from mutated genes and presented on cell surface ...
Abstract Background Tumor neoantigens are drivers of cancer immunotherapy response; however, current...
The remarkable clinical efficacy of the immune checkpoint blockade therapies has motivated researche...
Neoantigens are newly formed peptides created from somatic mutations that are capable of inducing tu...
Background: Tumor-specific mutations form novel immunogenic peptides called neoantigens. Neoantigens...
BACKGROUND The use of next-generation sequencing technologies has enabled the rapid identificatio...
Neoantigens are newly formed peptides formed by somatic mutations that are capable of inducing tumor...
Neoantigens are novel peptide sequences resulting from sources such as somatic mutations in tumors. ...
abstract: Cells become cancerous due to changes in their genetic makeup. In cancers, an altered amin...
The field of cancer neoantigen investigation has developed swiftly in the past decade. Predicting no...
Lack of a dedicated integrated pipeline for neoantigen discovery in mice hinders cancer immunotherap...
The field of cancer neoantigen investigation has developed swiftly in the past decade. Predicting no...
Cancer immunotherapy has become a new pillar of cancer treatment. However, durable clinical benefits...
The human adaptive immune system is programmed to distinguish between self and non-self proteins and...
BACKGROUND: Immune escape is one of the hallmarks of cancer and several new treatment approaches att...
Tumor-specific peptide epitopes that are generated from mutated genes and presented on cell surface ...
Abstract Background Tumor neoantigens are drivers of cancer immunotherapy response; however, current...
The remarkable clinical efficacy of the immune checkpoint blockade therapies has motivated researche...